NIR Stent Judgment Requires Boston Scientific to Pay $406.7 Million
October 1, 2008 - Boston Scientific Corp. said today the U.S. District Court in Delaware has entered judgment against the company in a case involving a patent owned by Johnson & Johnson and Boston Scientific’s NIR stent product.
In the judgment, the judge awarded Johnson & Johnson damages in the amount of $406.7 million and pre-judgment interest in the amount of $296.1 million.
Boston Scientific said it will appeal the judgment.
On Sept. 15, the Boston Scientific said the judge in this case had granted Johnson & Johnson’s motion for entry of judgment and had denied Boston Scientific’s motion for a new trial.
The original suit was filed in 1997. Boston Scientific has not sold the NIR stent since 2004.
For more information: www.bostonscientific.com
More like this
- Boston Scientific Announces Court Decision, Will Appeal
- Federal Court Says J&J Not Infringing on Boston’s DES Patent
- Appellate Court Rules in Favor of Boston Scientific in Stent Patent Case
- Court Rules in Favor of Boston Scientific in Stent Lawsuit
- Stent Makers Settle Three Patent Disputes for $1.7 Billion